InvestorsHub Logo
Followers 52
Posts 3345
Boards Moderated 0
Alias Born 10/26/2013

Re: None

Tuesday, 05/22/2018 8:12:50 PM

Tuesday, May 22, 2018 8:12:50 PM

Post# of 3283
Is Spectrum going to pull a nice surprise on us with data from their trial?

There'a a poster session titled

A phase 2 study of poziotinib in patients with EGFR or HER2 exon 20 mutation-positive non-small cell lung cancer

https://meetinglibrary.asco.org/record/165520/abstract

Never say never!